Home

Constantine Chinoporos

CIK 2014509 · See Remarks · last filed 2026-03-26

Constantine Chinoporos is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2024. The most recent filing, for GERN, was dated Mar 26, 2026. Across all open-market trades the lifetime net is −$17.3K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

6

Lifetime Open-Market Net

-$17.3K

Filer Profile

Reported Address
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK, NY 10017
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GERN Director — $1.57 — $0 1 2026-03-26
Applied Therapeutics, Inc. (APLT) Delisted See Remarks 0 $0.10 $0 -$17.3K 5 2026-02-03

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-26 GERN Grant (A) — $0 EDGAR
2026-02-03 Applied Therapeutics, Inc. (APLT) Delisted Mixed −619,611 $0 EDGAR
2025-03-26 Applied Therapeutics, Inc. (APLT) Delisted Grant (A) +350,000 $0 EDGAR
2025-03-06 Applied Therapeutics, Inc. (APLT) Delisted Sell (S) −447 -$197 EDGAR
2025-02-07 Applied Therapeutics, Inc. (APLT) Delisted Sell (S) −28,117 -$17.2K EDGAR
2024-03-18 Applied Therapeutics, Inc. (APLT) Delisted Grant (A) +300,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.